Ocata Therapeutics Inc (NASDAQ:OCAT)

6.36
Delayed Data
As of 3:59pm ET
 -0.14 / -2.15%
Today’s Change
4.95
Today|||52-Week Range
12.73
+4.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues39.5K39.5K39.5K39.5K
 
 
 
 
 
Cost of Goods Sold129.004.5K15.6K15.6K
 
 
 
 
 
Depreciation And Amortization31.0K33.4K45.0K63.7K
 
 
 
 
 
 
Operating ExpensesGross Income8.4K1.6K-21.2K-39.8K
 
 
 
 
 
General Expenses5.8M4.9M4.0M6.8M
 
 
 
 
 
Research And Development2.5M2.7M2.4M2.9M
 
 
 
 
 
Total Operating Expenses5.8M4.9M4.0M6.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-4.9M-4.0M-6.8M
 
 
 
 
 
Extraordinary Credit0.001.4M263.8K25.0K
 
 
 
 
Extraordinary Charge-2.7M-11.9M0.000.00
 
 
 
Interest Expense On Debt297.0K132.5K69.000.00
 
 
 
 
Other Expenses0.000.000.00-10.9K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.7M-15.5M-3.7M-6.8M
 
 
 
 
 
Preferred Dividend0.000.00-672.2K0.00
 
 
Net Income-8.7M-15.5M-3.7M-6.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.0M29.6M33.6M34.6M
 
 
 
 
 
Shares To Calculate EPS Diluted28.0M29.6M33.6M34.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$1.00-$0.13-$0.20
 
 
 
 
EPS Diluted-$0.31-$1.00-$0.13-$0.20
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account